220 related articles for article (PubMed ID: 17050932)
1. Cerebrotendinous xanthomatosis: need for early diagnosis.
Muhammed K; Nandakumar G; Saritha S
Indian J Dermatol Venereol Leprol; 2006; 72(5):364-6. PubMed ID: 17050932
[TBL] [Abstract][Full Text] [Related]
2. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
Takahashi M; Okazaki H; Tada H; Ishibashi S
J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
[TBL] [Abstract][Full Text] [Related]
3. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
Preiss Y; Santos JL; Smalley SV; Maiz A
Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
[TBL] [Abstract][Full Text] [Related]
4. Cerebrotendinous xanthomatosis.
Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
[TBL] [Abstract][Full Text] [Related]
5. Cerebrotendinous xanthomatosis (a rare lipid storage disorder): a case report.
Razi SM; Gupta AK; Gupta DC; Gutch M; Gupta KK; Usman SI
J Med Case Rep; 2016 Apr; 10(1):103. PubMed ID: 27094915
[TBL] [Abstract][Full Text] [Related]
6. [Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].
Campdelacreu J; Muñoz E; Cervera A; Jaumà S; Girós M; Tolosa E
Neurologia; 2002 Dec; 17(10):647-50. PubMed ID: 12487962
[TBL] [Abstract][Full Text] [Related]
7. A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene.
Gelzo M; Di Taranto MD; Bisecco A; D'Amico A; Capuano R; Giacobbe C; Caputo M; Cirillo M; Tedeschi G; Fortunato G; Corso G
Acta Neurol Belg; 2021 Apr; 121(2):561-566. PubMed ID: 31875301
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
[TBL] [Abstract][Full Text] [Related]
10. [Imaging of cerebrotendinous xanthomatosis].
Nagi S; Bouchriha M; Sebaï R; Marrakchi-Turki Z; Zouaoui W; Mrabet H; Megdiche H; Ben Slama C; Touibi S
J Radiol; 2006 Dec; 87(12 Pt 1):1883-6. PubMed ID: 17213773
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
Heller R; Grau AJ; Schäbitz WR; Schwaninger M
Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
[TBL] [Abstract][Full Text] [Related]
12. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M
J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188
[TBL] [Abstract][Full Text] [Related]
13. [Cerebrotendinous xanthomatosis: utility of nuclear magnetic resonance image in the follow-up and response to treatment].
Cuende E; Gómez-Rz de Mendarozqueta M; Vesga JC; Saracíbar N; Ibáñez-Avilés A; Castellano-Hurtado C
Rev Neurol; 1996 Dec; 24(136):1535-8. PubMed ID: 9064170
[TBL] [Abstract][Full Text] [Related]
14. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
[TBL] [Abstract][Full Text] [Related]
15. Cerebrotendinous xanthomatosis (CTX): a treatable lipid storage disease.
Keren Z; Falik-Zaccai TC
Pediatr Endocrinol Rev; 2009 Sep; 7(1):6-11. PubMed ID: 19696711
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of cerebrotendinous xanthomatosis].
Koyama S; Kato T
Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
[TBL] [Abstract][Full Text] [Related]
17. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress.
Gonzalez-Cuyar LF; Hunter B; Harris PL; Perry G; Smith MA; Castellani RJ
Redox Rep; 2007; 12(3):119-24. PubMed ID: 17623518
[TBL] [Abstract][Full Text] [Related]
18. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Moghadasian MH
Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis].
Pilo de la Fuente B; Sobrido MJ; Girós M; Pozo L; Lustres M; Barrero F; Macarrón J; Díaz M; Jiménez-Escrig A
Neurologia; 2011 Sep; 26(7):397-404. PubMed ID: 21345536
[TBL] [Abstract][Full Text] [Related]
20. A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene.
Stenos C; Kalafatakis K; Constantoulakis P; Zekiou K; Margoni A; Kardara P; Terentiou A; Stouraitis G; Nikolaou G
J Clin Lipidol; 2022; 16(3):281-285. PubMed ID: 35428606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
